TrialSignal
Clinical trial intelligence report
Enhancing Glycemic Index Knowledge and Application Among Adults With Type-2 Diabetes Mellitus
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 13, 2026
NCT ID
NCT03037099
Status
COMPLETED
Phase
Completed
Sponsor
Athabasca University
Executive brief
Investment-Ready Snapshot
The HEALD-GI study, sponsored by Athabasca University, aims to enhance dietary education focused on the Glycemic Index for adults with Type 2 Diabetes Mellitus (T2DM). With a growing global prevalence of diabetes, effective dietary management strategies are critical. This study's findings could inform future dietary interventions and educational programs, potentially leading to improved patient outcomes and reduced healthcare costs. The results may also position Athabasca University and its collaborators as leaders in diabetes management research, opening avenues for partnerships with healthcare providers and nutrition-focused organizations. The competitive landscape includes other diabetes education programs, but HEALD-GI's focus on GI may provide a unique selling proposition.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03037099
Indication
Type 2 Diabetes
Modality
behavioral intervention
Target
Glycemic Index (GI) dietary education and its impact on dietary behavior and glycemic control in adults with Type 2 Diabetes Mellitus.
Intervention
Enhanced GI Concept Education
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.